Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SomatoKine reduces insulin use, improves glycemic control in type I diabetes

March 3, 1999

Milestone achieved in Warner-Lambert/Unigene collaboration for oral calcitonin product

March 3, 1999

Naturally occurring inhibitors of cathepsins discovered at Sankyo

March 2, 1999

Agents for diabetes, impotence, lipid and cardiovascular disorders from Fujisawa

March 2, 1999

Lilly introduces new insulin dosing forms with improved convenience

March 1, 1999

Novo Nordisk discloses new potassium channel modulators and use in endocrine and other disorders

March 1, 1999

Schering-Plough initiates manufacture of Vasomax

March 1, 1999

Muse granted marketing approval in Germany

Feb. 26, 1999

Cortecs concludes phase III Macritonin trial

Feb. 26, 1999

Fujisawa's new hypoglycemic and hypolipidemic agents

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...